zepbound tirzepatide injection eli lilly Lowers Cost of Single-Dose Vials Lilly launches lower-price weight-loss drug

Filter results by status to show only recruiting or not yet recruiting studies

Postmenopausal women on semaglutide plus HT lost significantly more weight than those on semaglutide alone at every checkpoint: 3, 6, 9, and 12 months

If the FDA determines the signal is sufficient to warrant a label change, hair loss would be added to the prescribing information for semaglutide and tirzepatide which would require manufacturers Novo Nordisk and Eli Lilly to update their patient information materials

However, some patients switch from brand-name pens to compounded vials for cost reasons

Jaclyn Bjorklunds lawsuit states Novo Nordisk hid the risks of taking Ozempic

Annals of Pharmacotherapy, 29 (12), 12631273